vs
CECO ENVIRONMENTAL CORP（CECO）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
CECO ENVIRONMENTAL CORP的季度营收约是REPLIGEN CORP的1.0倍（$205.9M vs $197.9M），CECO ENVIRONMENTAL CORP同比增速更快（16.5% vs 13.6%），过去两年CECO ENVIRONMENTAL CORP的营收复合增速更高（22.4% vs 14.4%）
CECO环保是1966年成立的美国工业技术企业，总部位于得克萨斯州达拉斯，在纳斯达克上市，股票代码为CECO。公司面向制造、化工、能源、炼油等工业领域，提供空气污染治理相关的技术、产品及服务，助力工业客户满足环保排放要求。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CECO vs RGEN — 直观对比
营收规模更大
CECO
是对方的1.0倍
$197.9M
营收增速更快
CECO
高出2.9%
13.6%
两年增速更快
CECO
近两年复合增速
14.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $205.9M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | 31.0% | 52.5% |
| 营业利润率 | 0.9% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | 16.5% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $0.98 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CECORGEN
| Q1 26 | $205.9M | — | ||
| Q4 25 | $214.7M | $197.9M | ||
| Q3 25 | $197.6M | $188.8M | ||
| Q2 25 | $185.4M | $182.4M | ||
| Q1 25 | $176.7M | $169.2M | ||
| Q4 24 | $158.6M | $174.1M | ||
| Q3 24 | $135.5M | $154.9M | ||
| Q2 24 | $137.5M | $154.1M |
净利润CECORGEN
| Q1 26 | — | — | ||
| Q4 25 | $3.1M | $13.3M | ||
| Q3 25 | $1.5M | $14.9M | ||
| Q2 25 | $9.5M | $14.9M | ||
| Q1 25 | $36.0M | $5.8M | ||
| Q4 24 | $4.9M | $-30.3M | ||
| Q3 24 | $2.1M | $-654.0K | ||
| Q2 24 | $4.5M | $3.3M |
毛利率CECORGEN
| Q1 26 | 31.0% | — | ||
| Q4 25 | 35.1% | 52.5% | ||
| Q3 25 | 32.7% | 53.2% | ||
| Q2 25 | 36.2% | 50.0% | ||
| Q1 25 | 35.2% | 53.6% | ||
| Q4 24 | 35.8% | 26.1% | ||
| Q3 24 | 33.4% | 50.0% | ||
| Q2 24 | 35.7% | 49.8% |
营业利润率CECORGEN
| Q1 26 | 0.9% | — | ||
| Q4 25 | 7.7% | 9.0% | ||
| Q3 25 | 4.8% | 8.9% | ||
| Q2 25 | 9.7% | 7.6% | ||
| Q1 25 | 35.0% | 3.9% | ||
| Q4 24 | 7.1% | -17.7% | ||
| Q3 24 | 5.3% | -5.1% | ||
| Q2 24 | 6.7% | 1.0% |
净利率CECORGEN
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | 6.7% | ||
| Q3 25 | 0.8% | 7.9% | ||
| Q2 25 | 5.1% | 8.2% | ||
| Q1 25 | 20.4% | 3.4% | ||
| Q4 24 | 3.1% | -17.4% | ||
| Q3 24 | 1.5% | -0.4% | ||
| Q2 24 | 3.3% | 2.2% |
每股收益（稀释后）CECORGEN
| Q1 26 | $0.98 | — | ||
| Q4 25 | $0.09 | $0.24 | ||
| Q3 25 | $0.04 | $0.26 | ||
| Q2 25 | $0.26 | $0.26 | ||
| Q1 25 | $0.98 | $0.10 | ||
| Q4 24 | $0.14 | $-0.55 | ||
| Q3 24 | $0.06 | $-0.01 | ||
| Q2 24 | $0.12 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $45.4M | $767.6M |
| 总债务越低越好 | $5.3M | $542.2M |
| 股东权益账面价值 | $317.2M | $2.1B |
| 总资产 | $1.0B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.02× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CECORGEN
| Q1 26 | $45.4M | — | ||
| Q4 25 | $33.1M | $767.6M | ||
| Q3 25 | $32.8M | $748.7M | ||
| Q2 25 | $36.8M | $708.9M | ||
| Q1 25 | $146.5M | $697.2M | ||
| Q4 24 | $37.8M | $757.4M | ||
| Q3 24 | $38.7M | $784.0M | ||
| Q2 24 | $36.5M | $809.1M |
总债务CECORGEN
| Q1 26 | $5.3M | — | ||
| Q4 25 | $212.4M | $542.2M | ||
| Q3 25 | $220.9M | $537.9M | ||
| Q2 25 | $238.7M | — | ||
| Q1 25 | $339.7M | — | ||
| Q4 24 | $218.9M | $525.6M | ||
| Q3 24 | $133.4M | — | ||
| Q2 24 | $130.8M | — |
股东权益CECORGEN
| Q1 26 | $317.2M | — | ||
| Q4 25 | $317.5M | $2.1B | ||
| Q3 25 | $309.2M | $2.1B | ||
| Q2 25 | $298.4M | $2.1B | ||
| Q1 25 | $285.8M | $2.0B | ||
| Q4 24 | $247.7M | $2.0B | ||
| Q3 24 | $241.3M | $2.0B | ||
| Q2 24 | $235.0M | $2.0B |
总资产CECORGEN
| Q1 26 | $1.0B | — | ||
| Q4 25 | $893.8M | $2.9B | ||
| Q3 25 | $891.9M | $2.9B | ||
| Q2 25 | $876.6M | $2.9B | ||
| Q1 25 | $957.1M | $2.9B | ||
| Q4 24 | $759.7M | $2.8B | ||
| Q3 24 | $621.5M | $2.8B | ||
| Q2 24 | $598.1M | $2.9B |
负债/权益比CECORGEN
| Q1 26 | 0.02× | — | ||
| Q4 25 | 0.67× | 0.26× | ||
| Q3 25 | 0.71× | 0.26× | ||
| Q2 25 | 0.80× | — | ||
| Q1 25 | 1.19× | — | ||
| Q4 24 | 0.88× | 0.27× | ||
| Q3 24 | 0.55× | — | ||
| Q2 24 | 0.56× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流CECORGEN
| Q1 26 | — | — | ||
| Q4 25 | $10.0M | $25.7M | ||
| Q3 25 | $15.3M | $48.1M | ||
| Q2 25 | $-7.7M | $28.6M | ||
| Q1 25 | $-11.7M | $15.0M | ||
| Q4 24 | $1.8M | $39.2M | ||
| Q3 24 | $15.1M | $49.3M | ||
| Q2 24 | $6.7M | $42.2M |
自由现金流CECORGEN
| Q1 26 | — | — | ||
| Q4 25 | $7.3M | $17.6M | ||
| Q3 25 | $11.0M | $43.4M | ||
| Q2 25 | $-8.7M | $21.5M | ||
| Q1 25 | $-15.1M | $11.4M | ||
| Q4 24 | $-4.3M | $33.6M | ||
| Q3 24 | $11.1M | $42.3M | ||
| Q2 24 | $2.5M | $37.4M |
自由现金流率CECORGEN
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 8.9% | ||
| Q3 25 | 5.6% | 23.0% | ||
| Q2 25 | -4.7% | 11.8% | ||
| Q1 25 | -8.5% | 6.8% | ||
| Q4 24 | -2.7% | 19.3% | ||
| Q3 24 | 8.2% | 27.3% | ||
| Q2 24 | 1.9% | 24.3% |
资本支出强度CECORGEN
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 4.1% | ||
| Q3 25 | 2.1% | 2.5% | ||
| Q2 25 | 0.6% | 3.9% | ||
| Q1 25 | 1.9% | 2.1% | ||
| Q4 24 | 3.9% | 3.2% | ||
| Q3 24 | 3.0% | 4.5% | ||
| Q2 24 | 3.0% | 3.1% |
现金转化率CECORGEN
| Q1 26 | — | — | ||
| Q4 25 | 3.26× | 1.93× | ||
| Q3 25 | 10.18× | 3.23× | ||
| Q2 25 | -0.81× | 1.92× | ||
| Q1 25 | -0.33× | 2.57× | ||
| Q4 24 | 0.37× | — | ||
| Q3 24 | 7.24× | — | ||
| Q2 24 | 1.49× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
